Drugs that contain Dexamethasone; Tobramycin
1. Tobradex St patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8101582 | HARROW EYE | Topical ophthalmic compositions containing tobramycin and dexamethasone |
Dec, 2027
(3 years from now) | |
| US8450287 | HARROW EYE | Topical ophthalmic compositions containing tobramycin and dexamethasone |
Dec, 2027
(3 years from now) | |
| US7795316 | HARROW EYE | Topical ophthalmic compositions containing tobramycin and dexamethasone |
Aug, 2028
(4 years from now) | |
Market Authorisation Date: 13 February, 2009
Treatment: Use of a combination of tobramycin and dexamethasone to treat ocular inflammation where an infection or risk of infection exists
Dosage: SUSPENSION/DROPS;OPHTHALMIC
More Information on Dosage
TOBRADEX ST family patents
